Incannex Healthcare (IXHL) Cash & Equivalents (2020 - 2026)

Incannex Healthcare has disclosed Cash & Equivalents across 7 years of filings, most recently posting $74.5 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $74.5 million, up 1010.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.5 million (up 1010.12% YoY), and the FY2025 annual result was $15.0 million, up 154.9% from the prior year.
• Cash & Equivalents came in at $74.5 million for Q1 2026 at Incannex Healthcare, up from $68.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $74.5 million in Q1 2026 to a low of $2.1 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $14.8 million (2023), against an average of $27.8 million.
• Across the five-year window, Cash & Equivalents plunged 85.58% in 2024 and soared 3184.08% in 2025, its largest moves.
• Incannex Healthcare's Cash & Equivalents stood at $37.5 million in 2022, then plunged by 61.19% to $14.6 million in 2023, then slumped by 85.58% to $2.1 million in 2024, then jumped by 3184.08% to $68.9 million in 2025, then grew by 8.13% to $74.5 million in 2026.
• The last three Cash & Equivalents figures came in at $74.5 million (Q1 2026), $68.9 million (Q4 2025), and $73.3 million (Q3 2025), per Business Quant data.